SpheroMed: Personalized cancer therapy, services for patients and doctors
CompanySpheroTec GmbH, Munich, Germany
With the help of the new SpheroTest, the scientists at SpheroMed can investigate the effect of medication on the cells of an individual tumor before the start of therapy. SpheroTest uses tumor tissue from each patient to produce personalised 3D tumor spheroids that are subjected to different cancer medications. This enables scientists and medical doctors to determine how sensitive each patient's tumor is to various medications. This information is very important for the attending physician in order to be able to draw up an optimal treatment plan for the individual patient.
SpheroMed: Die individualisierte Krebstherapie
Barbara Mayer
Added on: 05-22-2020
[1] https://www.spherotec.com/
